Purchase Order 75N91025P00037
Award Date
12/8/24
Potential Completion Date
12/7/25
Potential Value
$15K
Federal Agency
National Cancer Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $17,508.94 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is not set aside for any special designation. Illumina has previously been awarded prime federal contracts and subcontracts by agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems, consumables, and...
This contract was awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $24,797.20 firm-fixed-price delivery order is for Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. No set-aside was used. Illumina has a history of providing these types of products and services to...
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract, valued at $209,924.10, is for the provision of reagents and consumables to support genomic sequencing and analysis. Illumina has previously received prime and subcontract awards from various federal agencies, including the NIH, CDC, USDA, and VA, to provide a range of sequencing...
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $24,230.96 contract provides Illumina sequencing systems, reagents, and services to support genomic research and diagnostics. The award is not associated with a set-aside program. Through past prime contract and subcontract awards, Illumina has...
This is a $263,862.50 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the procurement of laboratory equipment and supplies, specifically various Illumina sequencing systems, reagents, and consumables to support the NCI Surgery Branch's genetic sequencing needs. The award does not have a set-aside designation. Illumina has previously received other prime federal...
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $90,461.80 order is for reagents and consumables to support the agency's genomic sequencing and analysis needs. Illumina has previously received other prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems and related...
This is a $15,388.08 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract is for a service agreement for a MiSeq M05802 sequencing system, with a completion date of December 7, 2025. Illumina has previously received prime contracts and subcontracts from various federal agencies, including the NIH, CDC, USDA, and VA, to provide sequencing...
This firm fixed-price delivery order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomics analysis products. The $28,701.70 contract is for the provision of various Illumina sequencing instruments, reagents, and related services. This award does not have a set-aside designation. Through prior prime and subcontract awards, Illumina has supported...
This is a firm fixed price delivery order issued by the National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $87,834.20 award is for the provision of biological kits, Illumina sequencing systems, and related services. This order appears to be part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery, which supports nucleic...
This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $12,081.90. The contract is not designated as a set-aside. Illumina, a manufacturer of genetic sequencing equipment and supplies, will provide goods and services to support genomic sequencing and analysis for research and diagnostics purposes. The award is likely part of a larger Indefinite...